Relay Therapeutics, Inc. (RLAY)
18.96
+0.47
(+2.54%)
USD |
NASDAQ |
Oct 02, 16:00
18.63
-0.33
(-1.74%)
After-Hours: 20:00
Relay Therapeutics Market Cap : 4.143B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 4.143B |
| October 01, 2026 | 4.041B |
| September 30, 2026 | 3.944B |
| September 29, 2026 | 4.012B |
| September 28, 2026 | 3.866B |
| September 25, 2026 | 3.818B |
| September 24, 2026 | 3.875B |
| September 23, 2026 | 3.940B |
| September 22, 2026 | 4.229B |
| September 21, 2026 | 3.975B |
| September 18, 2026 | 4.117B |
| September 17, 2026 | 4.194B |
| September 16, 2026 | 4.117B |
| September 15, 2026 | 4.146B |
| September 14, 2026 | 4.165B |
| September 11, 2026 | 4.124B |
| September 10, 2026 | 4.128B |
| September 09, 2026 | 4.078B |
| September 08, 2026 | 4.176B |
| September 04, 2026 | 4.161B |
| September 03, 2026 | 4.154B |
| September 02, 2026 | 4.045B |
| September 01, 2026 | 4.041B |
| August 31, 2026 | 4.017B |
| August 28, 2026 | 4.102B |
| Date | Value |
|---|---|
| August 27, 2026 | 4.244B |
| August 26, 2026 | 4.253B |
| August 25, 2026 | 4.495B |
| August 24, 2026 | 4.318B |
| August 21, 2026 | 4.248B |
| August 20, 2026 | 4.305B |
| August 19, 2026 | 4.532B |
| August 18, 2026 | 4.504B |
| August 17, 2026 | 4.517B |
| August 14, 2026 | 4.340B |
| August 13, 2026 | 4.355B |
| August 12, 2026 | 4.386B |
| August 11, 2026 | 4.368B |
| August 10, 2026 | 4.358B |
| August 07, 2026 | 4.320B |
| August 06, 2026 | 4.316B |
| August 05, 2026 | 4.303B |
| August 04, 2026 | 4.270B |
| August 03, 2026 | 3.553B |
| July 31, 2026 | 3.563B |
| July 30, 2026 | 3.680B |
| July 29, 2026 | 3.476B |
| July 28, 2026 | 3.461B |
| July 27, 2026 | 3.527B |
| July 24, 2026 | 3.489B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 2.371B |
| Karyopharm Therapeutics, Inc. | 18.19M |
| Spyre Therapeutics, Inc. | 8.207B |
| Akebia Therapeutics, Inc. | 235.06M |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
Market Cap Related Metrics
| PS Ratio | 333.63 |
| Price to Book Value | 4.655 |
| Price | 18.96 |
| Earnings Yield | -8.26% |